Jazz Pharmaceuticals (JAZZ) Minority Interest (2014 - 2015)
Jazz Pharmaceuticals (JAZZ) posted quarterly Minority Interest of $14000.0 for Q3 2015, down 84.44% year-over-year from $90000.0 in Q3 2014, and down 74.55% quarter-over-quarter from $55000.0 in Q2 2015.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) Minority Interest (2014 - 2015) Analysis & Trends
Jazz Pharmaceuticals' Minority Interest history runs 2 years deep, the most recent figure standing at $14000.0 for Q3 2015.
- In Q3 2015, Minority Interest fell 84.44% year-over-year to $14000.0; the TTM figure through Sep 2015 stood at $14000.0 (down 84.44% YoY), while the FY2014 annual figure was $64000.0, changed N/A from the prior year.
- Minority Interest for Q3 2015 stood at $14000.0, down from $55000.0 in the prior quarter.
- The five-year high for Minority Interest was $17.6 million in Q1 2014, with the low at $14000.0 in Q3 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Jazz Pharmaceuticals | 15.60 Bn | 13.98 Bn | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 14,000.00 |
| Jun 30, 2015 | 55,000.00 |
| Mar 31, 2015 | 54,000.00 |
| Dec 31, 2014 | 64,000.00 |
| Sep 30, 2014 | 90,000.00 |
| Jun 30, 2014 | 396,000.00 |
| Mar 31, 2014 | 17.62 Mn |